Dr. Kenney conducts clinical outcomes research focused on childhood cancer survivors. She is a principal investigator on the Childhood Cancer Survivors Study (CCSS) in the areas of second primary cancers and chronic disease. Dr Kenney is also the principal investigator on institutional clinical studies investigating male reproductive function, renal function, and gastrointestinal disease in childhood cancer survivors. Research interests also include investigating models of clinical services to address the ongoing medical needs of childhood cancer survivors.
Research Background
Dr. Kenney received her MD at the State University of New York, Stony Brook School of Medicine, completed her Pediatric residency at Children's National Medical Center, Washington, DC and a pediatric hematology/oncology fellowship at Children's National Medical Center, Washington, DC. Focus of Research The goal of Dr. Kenney's research is to reduce morbidity associated with treatment of cancer during childhood by understanding the spectrum of treatment associated late effects and designing interventions to improve long term outcomes for survivors.
Education
Undergraduate School
Boston College
1985
Boston
MA
Medical School
SUNY at Stony Brook School of Medicine
1989
Stony Brook
NY
Internship
Pediatrics
Children's National Medical Center
1990
Washington
DC
Residency
Pediatrics
Children's National Medical Center
1992
Washington
DC
Fellowship
Pediatric Hematology-Oncology
Children's National Medical Center
1995
Washington
DC
Publications
Development and refinement of the Cardiovascular Health Equity through Food (CHEF) intervention for childhood cancer survivors. J Cancer Surviv. 2025 Jan 04. View Abstract
Correction to: Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 Apr 12. View Abstract
Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 02; 18(1):34-41. View Abstract
REPLY: Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy. JACC CardioOncol. 2023 Feb; 5(1):157. View Abstract
Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS). JAMA Oncol. 2022 Oct 13. View Abstract
Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study. Pediatr Blood Cancer. 2022 12; 69(12):e29942. View Abstract
Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation: A Delphi Study. Neurology. 2022 10 18; 99(16):e1755-e1766. View Abstract
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy. JACC CardioOncol. 2022 Sep; 4(3):354-367. View Abstract
Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study. JMIR Res Protoc. 2022 Jan 26; 11(1):e34033. View Abstract
Early parental knowledge of late effect risks in children with cancer. Pediatr Blood Cancer. 2022 02; 69(2):e29473. View Abstract
Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic. Pediatr Blood Cancer. 2021 06; 68(6):e28927. View Abstract
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e45-e56. View Abstract
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e57-e67. View Abstract
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e68-e80. View Abstract
Outcomes and implications of a single brain death examination policy on organ donation outcomes at a high-volume trauma center. J Trauma Acute Care Surg. 2020 12; 89(6):1166-1171. View Abstract
Aortic Aneurysm Natural Progression is Not Influenced by Concomitant Malignancy and Chemotherapy. Ann Vasc Surg. 2021 Feb; 71:29-39. View Abstract
Long-Term Psychosocial Well-Being and Quality of Life Among Childhood Cancer Survivors Who Developed a Subsequent Malignant Neoplasm. J Adolesc Young Adult Oncol. 2021 04; 10(2):240-245. View Abstract
Regional practice norms for the care of childhood cancer survivors at risk for cardiomyopathy: A Delphi study. Pediatr Blood Cancer. 2019 09; 66(9):e27868. View Abstract
The management of childhood cancer survivors at risk for stroke: A Delphi survey of regional experts. Pediatr Blood Cancer. 2018 12; 65(12):e27394. View Abstract
Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research. J Clin Oncol. 2018 07 20; 36(21):2160-2168. View Abstract
Barriers and facilitators to sexual and reproductive health communication between pediatric oncology clinicians and adolescent and young adult patients: The clinician perspective. Pediatr Blood Cancer. 2018 08; 65(8):e27087. View Abstract
Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017 Oct; 64(10). View Abstract
Preparing childhood cancer survivors for transition to adult care: The young adult perspective. Pediatr Blood Cancer. 2017 Oct; 64(10). View Abstract
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017 02; 18(2):e75-e90. View Abstract
Transition and transfer of childhood cancer survivors to adult care: A national survey of pediatric oncologists. Pediatr Blood Cancer. 2017 02; 64(2):346-352. View Abstract
Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations. Cancer. 2016 Jul 15; 122(14):2216-23. View Abstract
Fatigue in adolescent and adult survivors of non-CNS childhood cancer: a report from project REACH. Support Care Cancer. 2016 09; 24(9):3951-9. View Abstract
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016 05; 17(5):567-76. View Abstract
Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2016 Mar 20; 34(9):910-8. View Abstract
Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20; 32(21):2217-23. View Abstract
Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature. J Pediatr Hematol Oncol. 2014 Apr; 36(3):237-40. View Abstract
Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med. 2014; 7(1):43-51. View Abstract
Sexual function in childhood cancer survivors: a report from Project REACH. J Sex Med. 2013 Aug; 10(8):2084-93. View Abstract
Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol. 2013 Mar 20; 31(9):1239-47. View Abstract
Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol. 2012 Sep 20; 30(27):3408-16. View Abstract
The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1062-6. View Abstract
Health status of the oldest adult survivors of cancer during childhood. Cancer. 2010 Jan 15; 116(2):497-505. View Abstract
Secondary malignancies across the age spectrum. Semin Radiat Oncol. 2010 Jan; 20(1):67-78. View Abstract
Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009 Aug 20; 27(24):3901-7. View Abstract
Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004 Oct 19; 141(8):590-7. View Abstract
[Primary T-cell pulmonary lymphoma. A case report and review of the literature]. Arch Bronconeumol. 2002 Dec; 38(12):596-8. View Abstract
High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001 Feb 01; 91(3):613-21. View Abstract
Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001 Feb; 41(2):264-8. View Abstract
Increased incidence of cancer in infants in the U.S.: 1980-1990. Cancer. 1998 Apr 01; 82(7):1396-400. View Abstract
Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia. A Childrens Cancer Group/National Institutes of Health Report. Cancer. 1996 Jul 01; 78(1):169-76. View Abstract